Researchers at the Indian Institute of Technology Bombay have developed a gentler method to recover lab-grown T-cells, a crucial step in CAR T-cell therapy. Using the mild enzyme Accutase instead of harsher alternatives helps improve cell survival and preserve immune function. The approach enhances the reliability and efficiency of immunotherapy production, supports cost reduction, and strengthens India’s efforts to make advanced cancer treatments more affordable and accessible.
Click to View MoreResearchers at Northwestern University have redesigned a common chemotherapy drug using nanotechnology, making it up to 20,000 times more effective against cancer while minimizing side effects. By embedding the drug into spherical nucleic acids, the therapy targets cancer cells precisely, improving absorption and potency. This breakthrough could revolutionize cancer treatment and pave the way for advanced nanomedicine applications in oncology and beyond.
Click to View More
© 2026 iasgyan. All right reserved